For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Clotrimazole is a white powdered pharmaceutical used for treatment of dermatological and gynaecological fungal infections. Clotrimazole was synthesised in 1969 firstly and its chemical name is 1-[(2-chloro-phenyl)(diphenyl)methyl]-1H-imidazole). Its molecular formula is C22H17ClN2 and the molecular weight is 344.8 g/mol.Clotrimazole is an inhibitor of ergosterol biosynthesis. It has many ecotoxicological properties in common with a range of fungicides used in agriculture. Clotrimazole is a broad-spectrum antimycotic agent effective pathogenic dermophytes, yeasts, Candida, Trichophyton, etc.
Scope of the Report:
This report focuses on the Clotrimazole in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
China is the largest supplier of clotrimazole, the manufacturers in China have a total capacity of 160 MT. In last years, there are some manufacturers have exist this market due to the environmental policies. China is also a major consumption market with many pharmaceutical companies.
Europe and India are also the major manufacturing bases of clotrimazole. But the manufacturers in these regions generally have a relatively low capacity. Because of the policies about development of APIs in India, the India market will occupy larger share in the market.
The clotrimazole market is relatively stable. But all these manufacturers have low capacity utilization. To maintain the development of clotrimazole industry, manufacturers should develop new technology without environmental issues or find new applications for clotrimazole.
The worldwide market for Clotrimazole is expected to grow at a CAGR of roughly 1.6% over the next five years, will reach 5 million US$ in 2023, from 4 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
- Amoli Organics
- Ciron Group
- Halcyon Labs
- INFA Group
- Manus Aktteva
- Guangzhou Hanpu
- Jiangsu Yunyang
- Wuhan DKY
- Hubei Aoxiang
- Jintan Zhongxing
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Market Segment by Applications, can be divided into
- Tinea of Feed and Hands
- Tinea Corporis
There are 15 Chapters to deeply display the global Clotrimazole market.
Chapter 1, to describe Clotrimazole Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Clotrimazole, with sales, revenue, and price of Clotrimazole, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Clotrimazole, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Clotrimazole market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Clotrimazole sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source